Cargando…

Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets

Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being di...

Descripción completa

Detalles Bibliográficos
Autores principales: Crook, Zachary R., Sevilla, Gregory P., Friend, Della, Brusniak, Mi-Youn, Bandaranayake, Ashok D., Clarke, Midori, Gewe, Mesfin, Mhyre, Andrew J., Baker, David, Strong, Roland K., Bradley, Philip, Olson, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740061/
https://www.ncbi.nlm.nih.gov/pubmed/29269835
http://dx.doi.org/10.1038/s41467-017-02098-8
_version_ 1783287971471949824
author Crook, Zachary R.
Sevilla, Gregory P.
Friend, Della
Brusniak, Mi-Youn
Bandaranayake, Ashok D.
Clarke, Midori
Gewe, Mesfin
Mhyre, Andrew J.
Baker, David
Strong, Roland K.
Bradley, Philip
Olson, James M.
author_facet Crook, Zachary R.
Sevilla, Gregory P.
Friend, Della
Brusniak, Mi-Youn
Bandaranayake, Ashok D.
Clarke, Midori
Gewe, Mesfin
Mhyre, Andrew J.
Baker, David
Strong, Roland K.
Bradley, Philip
Olson, James M.
author_sort Crook, Zachary R.
collection PubMed
description Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being difficult to produce, owing to their complex disulfide connectivity. Here we describe a platform for identifying target-binding cystine-dense peptides using mammalian surface display, capable of interrogating high quality and diverse scaffold libraries with verifiable folding and stability. We demonstrate the platform’s capabilities by identifying a cystine-dense peptide capable of inhibiting the YAP:TEAD interaction at the heart of the oncogenic Hippo pathway, and possessing the potency and stability necessary for consideration as a drug development candidate. This platform provides the opportunity to screen cystine-dense peptides with drug-like qualities against targets that are implicated for the treatment of diseases, but are poorly suited for conventional approaches.
format Online
Article
Text
id pubmed-5740061
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57400612017-12-26 Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets Crook, Zachary R. Sevilla, Gregory P. Friend, Della Brusniak, Mi-Youn Bandaranayake, Ashok D. Clarke, Midori Gewe, Mesfin Mhyre, Andrew J. Baker, David Strong, Roland K. Bradley, Philip Olson, James M. Nat Commun Article Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being difficult to produce, owing to their complex disulfide connectivity. Here we describe a platform for identifying target-binding cystine-dense peptides using mammalian surface display, capable of interrogating high quality and diverse scaffold libraries with verifiable folding and stability. We demonstrate the platform’s capabilities by identifying a cystine-dense peptide capable of inhibiting the YAP:TEAD interaction at the heart of the oncogenic Hippo pathway, and possessing the potency and stability necessary for consideration as a drug development candidate. This platform provides the opportunity to screen cystine-dense peptides with drug-like qualities against targets that are implicated for the treatment of diseases, but are poorly suited for conventional approaches. Nature Publishing Group UK 2017-12-21 /pmc/articles/PMC5740061/ /pubmed/29269835 http://dx.doi.org/10.1038/s41467-017-02098-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Crook, Zachary R.
Sevilla, Gregory P.
Friend, Della
Brusniak, Mi-Youn
Bandaranayake, Ashok D.
Clarke, Midori
Gewe, Mesfin
Mhyre, Andrew J.
Baker, David
Strong, Roland K.
Bradley, Philip
Olson, James M.
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title_full Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title_fullStr Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title_full_unstemmed Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title_short Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
title_sort mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740061/
https://www.ncbi.nlm.nih.gov/pubmed/29269835
http://dx.doi.org/10.1038/s41467-017-02098-8
work_keys_str_mv AT crookzacharyr mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT sevillagregoryp mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT frienddella mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT brusniakmiyoun mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT bandaranayakeashokd mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT clarkemidori mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT gewemesfin mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT mhyreandrewj mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT bakerdavid mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT strongrolandk mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT bradleyphilip mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets
AT olsonjamesm mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets